CD68-and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and systematic review

被引：0
|
作者：
Chao, N. [1 ]
Xia, W. [1 ]
Yu, K. [1 ]
Yuan, H. [1 ]
Zhang, W. [1 ]
机构：
[1] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2637
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [31] Progress and current utility of radiomics in PET/CT study of non-metastatic breast cancer: A systematic review
    Ibarra, P. M. Carcamo
    Gonzalez, U. A. Lopez
    Hurtado, A. Esteban
    de la Cruz, M. A. Navas
    Valero, L. Asensio
    Domingo, S. Diez
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (02): : 83 - 92
  • [32] THE CLINICAL SIGNIFICANCE OF THE CD163+AND CD68+TUMOR-ASSOCIATED MACROPHAGES IN HIGH-RISK HPV-RELATED CERVICAL CANCER
    Wang, W.
    Chen, X.
    Ma, J.
    Han, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 911 - 911
  • [33] Clinical Significance of CD163+and CD68+Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer
    Chen, Xiao-Jing
    Han, Ling-Fei
    Wu, Xiang-Guang
    Wei, Wen-Fei
    Wu, Lan-Fang
    Yi, Hong-Yan
    Yan, Rui-Ming
    Bai, Xiang-yang
    Zhong, Mei
    Yu, Yan-hong
    Liang, Li
    Wang, Wei
    JOURNAL OF CANCER, 2017, 8 (18): : 3868 - 3875
  • [34] THE CLINICAL SIGNIFICANCE OF THE CD163+AND CD68+TUMOR-ASSOCIATED MACROPHAGES IN HIGH-RISK HPV-RELATED CERVICAL CANCER
    Wang, W.
    Chen, X.
    Ma, J.
    Han, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 411 - 411
  • [35] The impact of sarcopenia on survival among non-metastatic breast cancer patients: A systematic review
    Chen, Sharon
    Marcella, Elizabeth
    Wijovi, Felix
    Tancherla, Angeline
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2021, 32 : S303 - S303
  • [36] CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
    Bravaccini, Sara
    Maltoni, Roberta
    BREAST CANCER RESEARCH, 2019, 21 (1):
  • [37] Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
    Morgan, Eileen
    O'Neill, Colette
    Shah, Richa
    Langselius, Oliver
    Su, Yaqi
    Frick, Clara
    Fink, Hanna
    Bardot, Aude
    Walsh, Paul M.
    Woods, Ryan R.
    Gonsalves, Lou
    Nygard, Jan F.
    Negoita, Serban
    Ramirez-Pena, Esmeralda
    Gelmon, Karen
    Antone, Nicoleta
    Mutebi, Miriam
    Siesling, Sabine
    Cardoso, Fatima
    Gralow, Julie
    Soerjomataram, Isabelle
    Arnold, Melina
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [38] Correlation of Tumor-infiltrating lymphocytes with clinicopathological features and treatment outcomes in non-metastatic breast cancer patients
    Hegazy, Neamat Elsayed
    Motal, Haitham Mohsen Abdel
    Tayel, Hanan Yehia
    Ismail, Abdelsalam A.
    CANCER RESEARCH, 2021, 81 (04)
  • [39] CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
    Sara Bravaccini
    Roberta Maltoni
    Breast Cancer Research, 21
  • [40] Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment
    Jun Kinoshita
    Sachio Fushida
    Takahisa Yamaguchi
    Hideki Moriyama
    Hiroto Saito
    Mari Shimada
    Shiro Terai
    Koichi Okamoto
    Keishi Nakamura
    Itasu Ninomiya
    Shintaro Yagi
    Noriyuki Inaki
    BMC Cancer, 22
12345